Cargando…
Contribution of Estrone Sulfate to Cell Proliferation in Aromatase Inhibitor (AI) -Resistant, Hormone Receptor-Positive Breast Cancer
Aromatase inhibitors (AIs) effectively treat hormone receptor-positive postmenopausal breast cancer, but some patients do not respond to treatment or experience recurrence. Mechanisms of AI resistance include ligand-independent activation of the estrogen receptor (ER) and signaling via other growth...
Autores principales: | Higuchi, Toru, Endo, Megumi, Hanamura, Toru, Gohno, Tatsuyuki, Niwa, Toshifumi, Yamaguchi, Yuri, Horiguchi, Jun, Hayashi, Shin-ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882040/ https://www.ncbi.nlm.nih.gov/pubmed/27228187 http://dx.doi.org/10.1371/journal.pone.0155844 |
Ejemplares similares
-
Acquired resistance to everolimus in aromatase inhibitor-resistant breast cancer
por: Kimura, Mariko, et al.
Publicado: (2018) -
Individual transcriptional activity of estrogen receptors in primary breast cancer and its clinical significance
por: Gohno, Tatsuyuki, et al.
Publicado: (2012) -
The Role of Estrone in Feminizing Hormone Treatment
por: Tebbens, Marieke, et al.
Publicado: (2021) -
Estrone Sulfate Transport and Steroid Sulfatase Activity in Colorectal Cancer: Implications for Hormone Replacement Therapy
por: Gilligan, Lorna C., et al.
Publicado: (2017) -
Prognostic value of the ubiquitin ligase carboxyl terminus of the Hsc70‐interacting protein in postmenopausal breast cancer
por: Kurozumi, Sasagu, et al.
Publicado: (2016)